Product Information
ERYTHROMYCIN 500 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $2.7512 per EA under NDC 75834024301. Its NADAC has been published 233 times since Jan 12, 2022.
Strength
500 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834024301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA213628On Market Since
7/15/2021
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 500 MG TABLET has been published 233 times since Jan 12, 2022, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7512 per EA |
|---|---|
| All-time high | $13.2213 (May 11, 2022) |
| All-time low | $2.0242 (Aug 21, 2024) |
| 52-week high | $3.0999 |
| 52-week low | $2.7512 |
| Median price | $5.6270 |
| Average price | $5.9839 |
| Largest weekly change | +40.9% (Nov 20, 2024) |
| Weeks tracked | 233 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 500 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $2.7512 per EA (NDC 75834024301), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 500 MG TABLET has declined 79.2%. It has been tracked across 233 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 500 MG TABLET?
Since Jan 12, 2022, the NADAC for ERYTHROMYCIN 500 MG TABLET has ranged from a low of $2.0242 (Aug 21, 2024) to a high of $13.2213 (May 11, 2022), with a median of $5.6270 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 500 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ERYTHROMYCIN 500 MG TABLET, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 500 MG TABLET?
ERYTHROMYCIN 500 MG TABLET (NDC 75834024301) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification